Yingkai Zhang Group: Alumni
Postdoctoral Associates
- Chunyun Xiao, 10/2003-6/2008; currently, Professor of Physics,
Nanjing University of Science and Technology, Nanjing, P. R. China.
- Clemence Corminboeuf, 1/2005-1/2006; currently,
Professor, Ecole Polytechnique Federale de Lausanne, Switzerland.
- Shenglong Wang , 4/2005-10/2008; currently, Staff member,
Information Technology Services, New York University.
- Po Hu, 8/2008-2/2009; Subsequently, Postdoctoral Associate,
University of California at Berkley.
- Yanzi Zhou, 9/2007-1/2011;
currently, Associate Professor of Chemistry, Nanjing University,
Nanjing, P.R. China.
- Zhenyu Lu, 5/2006-8/2011; Currently, Morgan Stanley.
- Ruibo Wu, 4/2011-9/2011; currently, Professor, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, P. R. China.
- Yongle Li, 11/2013-10/2015; currently, Associate Professor, Department of Physics, and Institute of Quantum and Molecular Structures, Shanghai University, Shanghai, P. R. China.
- David Rooklin,04/2012-09/2017;currently, CEO, Redesign Science.
- Arunima Singh , 08/2016 - 07/2017; currently, Senior Editor, Nature Methods.
- Cheng Wang; 02/2017-12/2017; currently, senior software/machine learning eigineer, Alibaba Cloud, HangZhou, P. R. China.
- Xuben Hou, 8/2017-7/2018; currently, Associate Professor, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China.
Graduate Students
- Po Hu; Ph.D., 2008; Subsequently,
Postdoctoral Associate, University of California at Berkley.
- Han Zheng; Ph. D., 2009; currently,
quantitative developer in finance.
- Thomas Weingarten; Ph. D., 2012; currently, Google Inc.
- David Rooklin; Ph. D., 2012; currently,
CEO, Redesign Science.
- Gulseher Sarah Sirin; Ph. D., 2012; currently, Associate Director, Head of Computational Chemistry at Remix Therapeutics
, Boston.
- Nengjie Zhou; Ph. D., 2014; currently,CFA, Vice President at Oak Hill Advisors, L.P.,
New York.
- Xia Xiao; Ph. D., 2015; currently,
Microsoft China, Beijing.
- Yawei Shi; Ph. D., 2015; currently,Manager, Regulatory Affairs, CMC at AbbVie,
Chicago.
- Wenjing Gong; Ph. D., 2015; currently, Lince Group, Hunan
, P. R. China.
- Cheng Wang; Ph. D., 2017; currently, Senior Software/Machine Learning Eigineer, Alibaba Cloud, HangZhou, P. R. China.
- Haotian Li; M.S., 2019; currently,
CTO, Redesign Science.
- Joseph Katigbak; Ph. D., 2020; currently,
Data Scientist, Prognos Health.
- Yuwei Yang ; Ph. D., 2020; currently, research scientist, ByteDance AI Lab, Mountain View, CA.
- Jianing Lu; Ph. D., 2020; currently, Data Scientist, The Janssen Pharmaceutical Companies of Johnson & Johnson, New Jersey.
- Chao Yang; Ph.D., 2022; currently, Computational Chemist, Exo Therapeutics, Boston.
- Dongdong Zhang; Ph.D., 2022; currently,Machine Learning Specialist in Cheminformatics, Frontier Medicines, Boston.
- Jieyu (Jocelyn) Lu; Ph.D., 2022; currently, Research scientist, QuanMol Tech, Inc.
- Xiaokang Guo; Ph.D., 2022; currently, Postdoc Associate, New York University.
Visiting Graduate Students
- Zhihong Ke, 7/2007-8/2008;
currently,
Logitech, Suzhou, China.
- Ruibo Wu, 10/2008-9/2010; currently, Professor, School of Pharmaceutical Sciences, Sun Yat-Sen University,
Guangzhou, P. R. China.
- Xuben Hou, 10/2015-03/2017; currently, Associate Professor, School of Pharmaceutical Sciences, Shandong University.
Undergraduate Students
- Robert Fakheri,
10/05-5/07; B. S., 2007; subsequently, NYU Medical School.
- Jonathan Lai, 5/06-12/08;
B.S., 2008; subsequently, UIUC Graduate School.